Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant

• US 6,024,979 A
• Filed: 06/06/1995
• Issued: 02/15/2000
• Est. Priority Date: 06/06/1995
• Status: Expired due to Fees

• Current Assignee: Zoetis WHC 2 LLC (Zoetis Incorporated)
• Original Assignee: Solvay Animal Health, Inc.
• Inventors: Nichols, Eric, Danielson, Douglas W., Husband, Brent
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): Spear, James M.
• Application Number:
  US08/470,405
• Time in Patent Office: 1,715 Days
• Field of Search: 424/451, 424/464, 424/489, 424/442, 424/466, 424/423, 424/457, 424/468
• US Class Current: 424/451
• CPC Class Codes: A61K 31/496 Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• CPC Class Codes: A61K 9/0068 Rumen, e.g. rumen bolus
• CPC Class Codes: A61P 31/04 Antibacterial agents

Abstract

The present invention concerns a formulation for an oral veterinary composition containing a fluoroquinolone antimicrobial agent or a pharmaceutically acceptable salt thereof, and a method of treating a microbial infection in a ruminant. The present veterinary composition, when administered orally to a ruminating animal (e.g., a cow or a feedlot calf), allows the fluoroquinolone to be readily and extensively absorbed from the rumen into the circulating blood and provides an unexpectedly extended duration of therapeutic antimicrobial blood level.

Claims

1. A method of treating microbial infection in a ruminating or pre-ruminating ruminant, comprising orally administering to the ruminant a veterinary composition comprising a dosage of about 0.4-40 mg/kg of a fluoroquinolone or a pharmaceutically effective salt thereof in a pharmaceutically acceptable, orally acceptable inert carrier in the form of an oral bolus, wherein the composition provides therapeutic antimicrobial blood levels of said fluoroquinolone effective to treat a microbial infection in the ruminant for at least 24 hours, and wherein the microbial infection is caused by one or more of Staphylococcus, Lactobacillus, Streptococcus, Sarcina, Escherichia, Enterobacter, Klebsiella, Pseudomonas, Acinetobacter, Proteus, Citrobacter, Neisseria, Bacillus, Bacteroides, Peptococcus, Clostridium, Salmonella, Shigella, Serratia, Haemophilus, Pasteurella and Brucella.

2. The method of claim 1, wherein the fluoroquinolone is in a solid dosage form selected from the group consisting of a capsule, a tablet, a pill, a powder, a granule, an effervescing granule, a gel, a paste, a troche and a pastille.

3. The method of claim 1, wherein said fluoroquinolone is difloxacin.

4. The method of claim 1, wherein the therapeutic antimicrobial blood levels of said fluoroquinolone are maintained for at least 48 hours.

5. The method of claim 1, wherein said dosage is at least 1 gram of said fluoroquinolone or a free-base equivalent of said pharmacologically acceptable salt.

6. The method of claim 5, wherein said dosage is at least 1.5 grams of said fluoroquinolone or a free-base equivalent of said pharmacologically acceptable salt.

7. The method of claim 1, further consisting essentially of co-administering a second active agent to said ruminant.

8. The method of claim 1, wherein said ruminant is a member of a genus selected from the group consisting of Bos, Ovis, Capra, Lama and Bison.

9. The method of claim 8, wherein said ruminant is a member of the genus Bos.

10. The method of claim 9, wherein said ruminant is a member of the species Bos taurus.

11. The method of claim 1, consisting of orally administering said veterinary composition once daily or less frequently to said ruminant.

12. A composition for treating microbial infection in a ruminating or pre-ruminating ruminant, comprising a dosage of about 0.4-40 mg/kg of difloxacin or a pharmaceutically effective salt thereof in a pharmaceutically acceptable, orally acceptable inert carrier in the form of an oral bolus, wherein the composition provides therapeutic antimicrobial blood levels of said fluoroquinolone effective to treat a microbial infection in the ruminant for at least 24 hours.

13. The composition of claim 12, further comprising a second active agent.

14. The composition of claim 12, wherein said ruminant is a member of a genus selected from the group consisting of Bos, Ovis, Capra, Lama and Bison.

15. The composition of claim 12, wherein said ruminant is a member of the genus Bos.

16. The composition of claim 12, wherein said ruminant is a member of the species Bos taurus.

17. The composition of claim 12, wherein the microbial infection is caused by one or more of Staphylococcus, Lactobacillus, Streptococcus, Sarcina, Escherichia, Enterobacter, Klebsiella, Pseudomonas, Actinobacter, Proteus, Nitrobacter, Neisseria, Bacillus, Bacteroides, Peptococcus, Clostridium, Salmonella, Shigella, Serratia, Haemophilus, Pasteurella and Brucella.